life sciences statistics 2009- 2010 switzerlan d

Life Sciences Statistics 2009-2010

Switzerland

About UsThe following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology,Pharmaceutical and Medical Device industries. www.biotechgate.com

The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Basel Area, Berne Capital Area, BioAlps, Biopolo Ticino, Biotechnet, BioValley Basel, Greater Zurich Area, Medical Cluster, SIX Swiss Exchange, Swiss Biotech Association, Swiss Biotech . www.swisslifesciences.com

Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com

Status of the Sector

287 Total Biotechnology Companies

70 Biotech - Therapeutics

167 Biotech – R&D Services

50 Biotech - Other

>32'000 Employees

>1'000 R&D Employees

90% Percentage of SME's

5% Percentage of Companies Publicly Owned

CHF 606 m Financing / Capital Raised

61 Licensing Opportunities

Source: www.biotechgate.com

Key Activities of Biotechnology Companies

AgroBio 2%

Bioinformatics and

Bioelectronics 6%

Contract Research and Manufacturing

15%

Cosmetics 4%

Diagnostics and Analytical

Services 20%

Drug Delivery 3%

Environment 2%

Food and Nutraceuticals

3%

Genomics and Proteomics

3%

Industrial Biotechnology

1%

Other Services and Suppliers

25%

Therapeutics 14%

Veterinary 2%


Biotechnology Companies in SwitzerlandBreakdown by subcategory based on 475 entries by 287 companies

Biotechnology Company Size

1-10:36%

11-50:37%

51-250:17%

>25010%

Size of Biotechnology Companies in Switzerland(by number of employees)

Company Foundation Timeline

1 1 27

4 4 5

127 5 3

5 7

12

11

85

7

4

23

2

2

1

1

3

0

5

10

15

20

25

30

Biotechnology - Therapeutics Biotechnology / R&D Services Biotechnology - other

Company Foundations in Switzerland


Company Ownership

Private / independent

80%

Public 5%

Subsidiary 15%

Public, Private and Subsidiary Companies in Switzerland


Sources of Company Foundations

Independent foundation

44%

Management buy-out (MBO)

1%

Merger 2%

Spin-off from company

6%

Spin-off from public institution /

NPO 1%

Spin-off from university

25%

Subsidiary 13%

Other 8%

Sources of Company Foundations in Switzerland


Products in the Pipeline

133

28

42

12

0 20 40 60 80 100 120 140

Discovery & Preclinical

Phase I

Phase II

Phase III


Swiss Biotechnology Pipeline

5 Largest Therapeutic Biotech Company Financing Rounds

Company Date Currency Amount (millions) Type

ESBATech AG 14.09.2009 USD 150 Other

NovImmune 12.05.2009 CHF 62.5 Equity - Later stage

Molecular Partners AG 15.12.2009 CHF 46 Equity - Second stage

AC IMMUNE SA 26.01.2009 CHF 40 Equity - Later stage

Endosense SA 01.09.2009 USD 36 Equity - First stage


Biotechnology in Selected Countries

Austria Canada France Germany Italy Switzerland U.K.

Biotech companies 75 673 341 801 465 287 590

Therapeutic biotech companies 24 173 79 122 52 70 183

New companies founded in 2009 0 4 5 4 1 5 3

Companies founded 2000 - 2009 39 144 149 270 97 118 197

% of companies with <10 employees 31% 35% 35% 28% 31% 36% 27%

Biotech products in development 51 306 741 225 142 215 266

% publicly listed companies 1% 18% 6% 4% 3% 5% 13%


About Biotechgate

Biotechgate contains over 18’000 high-quality company profiles including company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves and an experienced database team to ensure the accuracy and relevance of the data.

To register for free or learn more about the different subscription options, please visit www.biotechgate.com.

Terms of Use

The „Swiss Life Sciences Survey“ is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation include the figures and information entered in this database and we do not guarantee any accuracy hereof.

A new categorization system was installed during 2007; therefore, subsequent surveys cannot be directly compared with surveys of years prior to 2007.

The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.

Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich [email protected] www.venturevaluation.com

life sciences statistics 2009- 2010 switzerlan d

Documents